COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
MIR29C |
|
microRNA 29c
|
|
|
0.496 |
0.808 |
MIR10B |
|
microRNA 10b
|
|
|
0.509 |
0.808 |
ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
MIR139 |
|
microRNA 139
|
|
|
0.527 |
0.808 |
MIR134 |
|
microRNA 134
|
|
|
0.542 |
0.769 |
LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
HSP90B2P |
Q58FF3
|
heat shock protein 90 beta family member 2, pseudogene
|
Chaperone
|
|
0.558 |
0.846 |
ERVK-18 |
|
endogenous retrovirus group K member 18
|
|
|
0.560 |
0.654 |
MIR495 |
|
microRNA 495
|
|
|
0.573 |
0.654 |
MIRLET7D |
|
microRNA let-7d
|
|
|
0.579 |
0.692 |
CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
MIR331 |
|
microRNA 331
|
|
|
0.612 |
0.615 |
PRS |
|
Prieto X-linked mental retardation syndrome
|
|
|
0.663 |
0.615 |
BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
ST11 |
|
suppression of tumorigenicity 11 (pancreas)
|
|
|
0.722 |
0.346 |
SAMMSON |
|
survival associated mitochondrial melanoma specific oncogenic non-coding RNA
|
|
|
0.780 |
0.231 |
FHP1 |
|
fumarate hydratase pseudogene 1
|
|
|
1.000 |
0.077 |